U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been...
Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published...
Thousands of healthy volunteers, including hundreds of Canadians, have offered to try getting injected with a potential vaccine and then purposely becoming infected with COVID-19 to test if the...
Jonathan Kimmelman, director of biomedical ethics at Ï㽶ÊÓƵ, agreed companies have some obligation to continue to provide care for patients who take part in studies to test experimental...
I talked this over with Ï㽶ÊÓƵ medical ethicist Jonathan Kimmelman, who specializes in the risks of medical experiments and has written a book about them centered on the Jesse Gelsinger...
Cancer scientists overestimate the extent to which high-profile preclinical studies can be successfully replicated, new research from Ï㽶ÊÓƵ suggests.
Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to a new study from Ï㽶ÊÓƵ in Canada.
RSS